Stay updated on BI 695500 vs Rituxan in Low Tumor Burden Follicular Lymphoma Clinical Trial
Sign up to get notified when there's something new on the BI 695500 vs Rituxan in Low Tumor Burden Follicular Lymphoma Clinical Trial page.

Latest updates to the BI 695500 vs Rituxan in Low Tumor Burden Follicular Lymphoma Clinical Trial page
- Check3 days agoChange DetectedThe site footer now identifies the platform as revision v3.8.0 instead of v3.7.2.SummaryDifference0.2%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedA general NIH notice about its terminology transition appears above the page, and the site revision changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check24 days agoChange DetectedThe study record remains inaccessible, displaying a 403 Forbidden error rather than trial details.SummaryDifference0.2%

- Check31 days agoChange DetectedThe site revision label changed from v3.7.0 to v3.7.1 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check45 days agoChange DetectedThe page now displays a 403 Forbidden error, blocking access to the study record and removing the usual trial content from view.SummaryDifference17%

- Check52 days agoChange DetectedThe page now displays Revision: v3.7.0, replacing Revision: v3.6.6. This reflects a site version update rather than changes to the trial details.SummaryDifference0.1%

Stay in the know with updates to BI 695500 vs Rituxan in Low Tumor Burden Follicular Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BI 695500 vs Rituxan in Low Tumor Burden Follicular Lymphoma Clinical Trial page.